Imperva (NASDAQ:IMPV) has been assigned a $56.00 target price by Evercore ISI in a research note issued on Friday. The brokerage presently has a “buy” rating on the software maker’s stock. Evercore ISI’s price target indicates a potential upside of 25.70% from the stock’s previous close.
A number of other research firms have also weighed in on IMPV. Zacks Investment Research upgraded Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price on the stock in a report on Tuesday, October 24th. Piper Jaffray Companies lowered Imperva from an “overweight” rating to a “neutral” rating and set a $42.00 target price on the stock. in a report on Monday, October 16th. Morgan Stanley restated an “underweight” rating and issued a $39.00 target price on shares of Imperva in a report on Thursday, November 9th. Royal Bank of Canada restated a “buy” rating and issued a $49.00 target price on shares of Imperva in a report on Wednesday, October 18th. Finally, BidaskClub upgraded Imperva from a “hold” rating to a “buy” rating in a report on Wednesday. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $52.57.
Shares of Imperva (NASDAQ:IMPV) traded up $2.50 during trading hours on Friday, reaching $44.55. The company’s stock had a trading volume of 216,665 shares, compared to its average volume of 281,396. The company has a market capitalization of $1,471.10, a price-to-earnings ratio of 165.27 and a beta of 1.79. Imperva has a 1-year low of $37.17 and a 1-year high of $52.40.
A number of institutional investors have recently modified their holdings of IMPV. SG Americas Securities LLC bought a new stake in Imperva during the third quarter worth $134,000. First Quadrant L P CA bought a new stake in Imperva during the third quarter worth $136,000. Ameritas Investment Partners Inc. lifted its holdings in Imperva by 18.7% during the second quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after acquiring an additional 464 shares during the period. Amalgamated Bank bought a new stake in Imperva during the second quarter worth $206,000. Finally, Principal Financial Group Inc. bought a new stake in Imperva during the second quarter worth $223,000. Institutional investors and hedge funds own 96.61% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Evercore ISI Analysts Give Imperva (IMPV) a $56.00 Price Target” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://sportsperspectives.com/2018/02/09/evercore-isi-analysts-give-imperva-impv-a-56-00-price-target.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.